PO-464 Endoglin-targeted therapy demonstrates strong preclinical anti-tumour activity in ewing sarcoma using antibody-drug conjugates by Puerto-Camacho, P, Lamhamedi-Cherradi, SE, Menegaz, BA, Castillo-Écija, H, Jordán-Pérez, C, Ferrer, C, Fabre, M, Carcaboso, ÁM, Ludwig, JA, De Álava, E

Get full text

345 - Targeting Ewing Sarcoma cells and the tumor microenvironment with OMTX003 anti-endoglin monoclonal antibodies by Camacho, P. Puerto, Amaral, A.T., Ordoñez, J.L., Robles, M.J., Domínguez, S., Peréz, C. Jordán, Biscuola, M., Álvarez, M. López, Fabre, M., Alava, E.

Get full text

Targeting Ewing Sarcoma cells and the tumor microenvironment with OMTX003 anti-endoglin monoclonal antibodies by Camacho, P. Puerto, Amaral, A.T, Ordoñez, J.L, Robles, M.J, Domínguez, S, Peréz, C. Jordán, Biscuola, M, Álvarez, M. López, Fabre, M, Alava, E

Get full text

Hippo pathway effectors YAP1/TAZ induce an EWS–FLI1‐opposing gene signature and associate with disease progression in Ewing sarcoma by Rodríguez‐Núñez, Pablo, Romero‐Pérez, Laura, Amaral, Ana T, Puerto‐Camacho, Pilar, Jordán, Carmen, Marcilla, David, Grünewald, Thomas GP, Alonso, Javier, Alava, Enrique, Díaz‐Martín, Juan

Get full text

Endoglin and MMP14 Contribute to Ewing Sarcoma Spreading by Modulation of Cell–Matrix Interactions by Puerto-Camacho, Pilar, Díaz-Martín, Juan, Olmedo-Pelayo, Joaquín, Bolado-Carrancio, Alfonso, Salguero-Aranda, Carmen, Jordán-Pérez, Carmen, Esteban-Medina, Marina, Álamo-Álvarez, Inmaculada, Delgado-Bellido, Daniel, Lobo-Selma, Laura, Dopazo, Joaquín, Sastre, Ana, Alonso, Javier, Grünewald, Thomas G. P., Bernabeu, Carmelo, Byron, Adam, Brunton, Valerie G., Amaral, Ana Teresa, Álava, Enrique De

Get full text